Associate Professor, Medical Oncology, Internal Medicine, University of Utah Huntsman Cancer Institute.
Oncology
Dr. Neeraj P. Agarwal, MD
|
|
Give Review
Neeraj Agarwal works in the field of Oncology. He researched medicine at Assam Medical College. He over the years received 10 awards: "Cancer Clinical Investigator Team Leadership Award", "Medical Student Rotation (MSR) Mentor Award", "William D. Odell Young Investigator Award", "America's Top Physicians", "Scholarship Award", "Fellow Research Award", "Winner, Clinical Vignette Competition", "Finalist, Research Poster Competition", "Merck Travel Award" and "Resident (PGY1) of the year". Neeraj P. Agarwal is a published doctor as well. He has 46 publications published. The latest was: Ruffling the Immunotherapy Response Paradigm with a Novel Personalized Peptide Vaccine. Neeraj Agarwal accepts Medicare.
Publications
- A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.
- Ruffling the Immunotherapy Response Paradigm with a Novel Personalized Peptide Vaccine.
- Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin.
- Activin receptor inhibitors-dalantercept.
- Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castratio...
- Kidney Cancer, version 3.2015.
- Ipilimumab in the treatment of prostate Cancer.
- Sequencing systemic therapies for metastatic kidney Cancer.
- Activity of enzalutamide in men with metastatic castration-resistant prostate Cancer is affected by prior treatment with abiraterone and/or docetaxel.
- Prostate Cancer risk prediction based on complete prostate Cancer family history.
- Correlation of Degree of Hypothyroidism With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor T...
- Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate Cancer trial.
- Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma.
- New prostate Cancer drugs: extending and improving life.
- Retrospective Analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
- Blood pressure, salivary cortisol, and inflammatory cytokine outcomes in senior female Cancer survivors enrolled in a tai chi chih randomized controlled trial.
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Co...
- Identification of specific Y chromosomes associated with increased prostate Cancer risk.
- A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial Carcinoma.
- Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-Analysis.
- The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer...
- New agents for prostate Cancer.
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Res...
- Kidney Cancer, version 2.2014.
- Management of hormone-sensitive metastatic prostate Cancer.
- Levels of fatigue and distress in senior prostate Cancer survivors enrolled in a 12-week randomized controlled trial of Qigong.
- Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma.
- Differing leukocyte gene expression profiles associated with fatigue in patients with prostate Cancer versus chronic fatigue syndrome.
- Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate Cancer (SWOG S0421): a randomised phase 3 trial.
- Pulmonary complications with the use of mTOR inhibitors in targeted Cancer therapy: a systematic review and meta-analysis.
- Metabolic complications with the use of mTOR inhibitors for Cancer therapy.
- Meta-Analysis of nephrotoxicity in patients with solid tumors treated with Cisplatin versus non-Cisplatin regimens with sub-group Analyses based on renal eligibility c...
- Risk of death at one year in patients with non-small cell lung Cancer (nsclc) treated with Cisplatin regimens: an indirect comparison meta-analysis based on renal elig...
- Feasibility and Acceptability of a Tai Chi Chih Randomized Controlled Trial in Senior Female Cancer Survivors.
- Management of Castrate Resistant Prostate Cancer-Recent Advances and Optimal Sequence of Treatments.
- Pooled Analysis of Phase II Trials Evaluating Weekly or Conventional Cisplatin as First-Line Therapy for Advanced Urothelial Carcinoma.
- Development of novel immune interventions for prostate Cancer.
- Novel molecular targets for the therapy of castration-resistant prostate Cancer.
- Hematopoiesis is not clonal in healthy elderly women.
- Emerging molecularly targeted therapies in castration refractory prostate Cancer.
- Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.
- Patient and provider attitudes toward genomic testing for prostate Cancer susceptibility: a mixed method study.
- A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate Cancer.
- Novel molecular aberrations and pathologic findings in a tubulocystic variant of renal Cell carcinoma.
- Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.
Schools
Assam Medical College
Ravenswood Hospital
University Iowa Hospital
University Iowa Clinics
University Utah Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Geriatric Medicine
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Cancer Clinical Investigator Team Leadership Award
- Medical Student Rotation (MSR) Mentor Award
- William D. Odell Young Investigator Award
- America's Top Physicians
- Scholarship Award
- Fellow Research Award
- Winner, Clinical Vignette Competition
- Finalist, Research Poster Competition
- Merck Travel Award
- Resident (PGY1) of the year
Education
-
University of Utah -
University of Iowa Hospitals and Clinics -
Assam Medical College
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1417078221 | |
| NPPES Provider LastName | AGARWAL | |
| NPPES Provider FirstName | NEERAJ | |
| NPPES Provider ZIPCode | 841125500 | |
| NPPES Provider State | UT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 223.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417078221 |
| Last Name Of The Provider | AGARWAL |
| First Name Of The Provider | NEERAJ |
| View All |
Similar Doctors
|
|
Dr. Cherie P. Brunker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vishnu N. Sundaresh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert V. Smith, MD |
|
|
Dr. Srinivas K. Tantravahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason G. Chandler, DMD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wallace L. Akerley III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Birgitta H. Mitchell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theresa L. Werner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xylina T. Gregg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristi J. Smock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harmon J. Eyre, MD |
|
|
Dr. Kenneth F. Grossmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Linford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Launce G. Gouw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasiliki Leventaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guido J. Tricot, MD |
|
Dr. W G. Harker, MD |
|
|
Dr. Sunil Sharma, MD
This Doctor is OpenDoctor Recommended.
|